胆道梗阻和胃出口梗阻联合治疗:胆道支架置入术和十二指肠衍生术在再干预风险方面的比较:专家单中心经验。

IF 1.7 4区 医学 Q3 GASTROENTEROLOGY & HEPATOLOGY
Jean-Michel Gonzalez, Ivann Bouteiller, Diane Lorenzo, Mohamed Gasmi, Marc Barthet
{"title":"胆道梗阻和胃出口梗阻联合治疗:胆道支架置入术和十二指肠衍生术在再干预风险方面的比较:专家单中心经验。","authors":"Jean-Michel Gonzalez, Ivann Bouteiller, Diane Lorenzo, Mohamed Gasmi, Marc Barthet","doi":"10.1080/00365521.2025.2537895","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Double malignant biliary and duodenal obstruction is a frequent and debilitating complication of advanced biliopancreatic cancers. Endoscopic ultrasound (EUS)-guided biliary and enteric drainage techniques have emerged as alternatives to ERCP and duodenal stenting (DS), but optimal therapeutic sequencing remains unclear.</p><p><strong>Patients and methods: </strong>We conducted a retrospective monocentric study including 34 patients treated for DMBO-DDO between February 2015 and December 2023. Inclusion required histologically confirmed tumors with both distal malignant biliary obstruction (DMBO) and high-grade gastric outlet obstruction (GOO). Treatment sequences were guided by the first symptom and validated by a multidisciplinary team. The primary endpoint was biliary reintervention rate according to different therapeutic combinations. Secondary endpoints included technical and clinical success, adverse events, and global reintervention rates.</p><p><strong>Results: </strong>Mean patient age was 75 years, with pancreatic adenocarcinoma being the most common (58.8%). ERCP was the first procedure in 67.6% of cases. Technical success was 100% for all biliary interventions. The overall biliary reintervention rate was 52.9%, significantly higher in ERCP-based strategies (up to 77.8%) compared to EUS-guided approaches (18.2%-40%; <i>p</i> = 0.03). Lower initial bilirubin levels (<150 μmol/L) were also associated with increased reintervention rates (77.2% vs. 23.5%; <i>p</i> = 0.019). Complication rates were low (4.4% for grade ≥ III).</p><p><strong>Conclusions: </strong>ERCP-first strategies for DMBO in the association of GOO showed significantly higher biliary reintervention rates compared to EUS-guided approaches. These findings suggest that EUS-based drainage should be favored in selected patients. Prospective multicenter studies are needed to refine treatment algorithms and confirm predictive factors for reintervention.</p>","PeriodicalId":21461,"journal":{"name":"Scandinavian Journal of Gastroenterology","volume":" ","pages":"958-965"},"PeriodicalIF":1.7000,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Combined biliary obstruction and gastric outlet obstruction management: comparison of various strategies of biliary stenting and duodenal derivation in terms of reintervention risk: an expert single-center experience.\",\"authors\":\"Jean-Michel Gonzalez, Ivann Bouteiller, Diane Lorenzo, Mohamed Gasmi, Marc Barthet\",\"doi\":\"10.1080/00365521.2025.2537895\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>Double malignant biliary and duodenal obstruction is a frequent and debilitating complication of advanced biliopancreatic cancers. Endoscopic ultrasound (EUS)-guided biliary and enteric drainage techniques have emerged as alternatives to ERCP and duodenal stenting (DS), but optimal therapeutic sequencing remains unclear.</p><p><strong>Patients and methods: </strong>We conducted a retrospective monocentric study including 34 patients treated for DMBO-DDO between February 2015 and December 2023. Inclusion required histologically confirmed tumors with both distal malignant biliary obstruction (DMBO) and high-grade gastric outlet obstruction (GOO). Treatment sequences were guided by the first symptom and validated by a multidisciplinary team. The primary endpoint was biliary reintervention rate according to different therapeutic combinations. Secondary endpoints included technical and clinical success, adverse events, and global reintervention rates.</p><p><strong>Results: </strong>Mean patient age was 75 years, with pancreatic adenocarcinoma being the most common (58.8%). ERCP was the first procedure in 67.6% of cases. Technical success was 100% for all biliary interventions. The overall biliary reintervention rate was 52.9%, significantly higher in ERCP-based strategies (up to 77.8%) compared to EUS-guided approaches (18.2%-40%; <i>p</i> = 0.03). Lower initial bilirubin levels (<150 μmol/L) were also associated with increased reintervention rates (77.2% vs. 23.5%; <i>p</i> = 0.019). Complication rates were low (4.4% for grade ≥ III).</p><p><strong>Conclusions: </strong>ERCP-first strategies for DMBO in the association of GOO showed significantly higher biliary reintervention rates compared to EUS-guided approaches. These findings suggest that EUS-based drainage should be favored in selected patients. Prospective multicenter studies are needed to refine treatment algorithms and confirm predictive factors for reintervention.</p>\",\"PeriodicalId\":21461,\"journal\":{\"name\":\"Scandinavian Journal of Gastroenterology\",\"volume\":\" \",\"pages\":\"958-965\"},\"PeriodicalIF\":1.7000,\"publicationDate\":\"2025-10-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Scandinavian Journal of Gastroenterology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1080/00365521.2025.2537895\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2025/8/21 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q3\",\"JCRName\":\"GASTROENTEROLOGY & HEPATOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Scandinavian Journal of Gastroenterology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1080/00365521.2025.2537895","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/8/21 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"GASTROENTEROLOGY & HEPATOLOGY","Score":null,"Total":0}
引用次数: 0

摘要

背景:胆道和十二指肠双恶性梗阻是晚期胆道胰腺癌的常见并发症。超声内镜(EUS)引导下的胆道和肠内引流技术已成为ERCP和十二指肠支架置入(DS)的替代方案,但最佳治疗顺序尚不清楚。患者和方法:我们进行了一项回顾性单中心研究,包括2015年2月至2023年12月期间接受dbo - ddo治疗的34例患者。纳入需要组织学证实的肿瘤同时伴有远端恶性胆道梗阻(DMBO)和高度胃出口梗阻(GOO)。治疗顺序以第一症状为指导,并由多学科团队进行验证。主要终点是不同治疗组合的胆道再干预率。次要终点包括技术和临床成功、不良事件和全球再干预率。结果:患者平均年龄75岁,以胰腺腺癌最常见(58.8%)。在67.6%的病例中,ERCP是首选手术。所有胆道干预的技术成功率为100%。总体胆道再干预率为52.9%,基于ercp的策略(高达77.8%)明显高于eus引导的方法(18.2%-40%;p = 0.03)。初始胆红素水平降低(p = 0.019)。并发症发生率低(≥III级为4.4%)。结论:与eus引导的方法相比,ercp优先策略在粘连的DMBO中显示出显着更高的胆道再干预率。这些发现表明,在选定的患者中,应优先采用基于eus的引流。需要前瞻性的多中心研究来完善治疗算法并确认再干预的预测因素。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Combined biliary obstruction and gastric outlet obstruction management: comparison of various strategies of biliary stenting and duodenal derivation in terms of reintervention risk: an expert single-center experience.

Background: Double malignant biliary and duodenal obstruction is a frequent and debilitating complication of advanced biliopancreatic cancers. Endoscopic ultrasound (EUS)-guided biliary and enteric drainage techniques have emerged as alternatives to ERCP and duodenal stenting (DS), but optimal therapeutic sequencing remains unclear.

Patients and methods: We conducted a retrospective monocentric study including 34 patients treated for DMBO-DDO between February 2015 and December 2023. Inclusion required histologically confirmed tumors with both distal malignant biliary obstruction (DMBO) and high-grade gastric outlet obstruction (GOO). Treatment sequences were guided by the first symptom and validated by a multidisciplinary team. The primary endpoint was biliary reintervention rate according to different therapeutic combinations. Secondary endpoints included technical and clinical success, adverse events, and global reintervention rates.

Results: Mean patient age was 75 years, with pancreatic adenocarcinoma being the most common (58.8%). ERCP was the first procedure in 67.6% of cases. Technical success was 100% for all biliary interventions. The overall biliary reintervention rate was 52.9%, significantly higher in ERCP-based strategies (up to 77.8%) compared to EUS-guided approaches (18.2%-40%; p = 0.03). Lower initial bilirubin levels (<150 μmol/L) were also associated with increased reintervention rates (77.2% vs. 23.5%; p = 0.019). Complication rates were low (4.4% for grade ≥ III).

Conclusions: ERCP-first strategies for DMBO in the association of GOO showed significantly higher biliary reintervention rates compared to EUS-guided approaches. These findings suggest that EUS-based drainage should be favored in selected patients. Prospective multicenter studies are needed to refine treatment algorithms and confirm predictive factors for reintervention.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
3.40
自引率
5.30%
发文量
222
审稿时长
3-8 weeks
期刊介绍: The Scandinavian Journal of Gastroenterology is one of the most important journals for international medical research in gastroenterology and hepatology with international contributors, Editorial Board, and distribution
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信